ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions
View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm
The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

A. Bushell,1 J. van der Net,1,2 D. Game,3 R. Hilton,3 S. Thirkell,4 P. Friend,2 E. Geissler,5 K. Wood,1 P. Harden,2 G. Lombardi.4

Poster Session D: Late Breaking  •  Halls C&D
6:00pm-7:00pm
Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.

J. Schwartz, S. Wilson, F. Shi, N. Undre, M. Kumar.

Poster Session D: Late Breaking  •  Halls C&D
6:00pm-7:00pm
Three Months of Weekly Rifapentine Plus Isoniazid for Latent Tuberculosis Treatment in Solid Organ Transplant Candidates.

B. Knoll,1 R. Nog,1 Y. Wu,2 A. Dhand.1

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D
6:00pm-7:00pm
Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.

C. Schwarz,1 A. Lawitschka,2 G. Böhmig,3 E. Dauber,4 H. Greinix,5 N. Kozakowski,6 F. Mühlbacher,1 G. Berlakovich,1 T. Wekerle.7

Poster Session D: Clinical Science: Tolerance: Clinical Studies  •  Halls C&D
6:00pm-7:00pm
Thrombalexin: Detection & Efficacy of a Membrane-Bound Anti-Thrombin Agent.

M. Manook,1,2 J. Kwun,1 J. Yoon,1 S. Sacks,2 A. Dorling,2 N. Mamode,2 R. Smith,2 S. Knechtle.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Thrombotic Microangiopathy After Kidney Transplantation: A Rare but Serious Complication.

C. Teixeira, I. Pietrobom, A. Lima, N. Tenório, G. Basso, M. Cristelli, L. Viana, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.

Poster Session D: Poster Session II: Kidney Complications-Other  •  Halls C&D
6:00pm-7:00pm
Tissue Priming of Plasmacytoid Dendritic Cells Enhances Their Phagocytosis and Lowers the Threshold for Subsequent Toll-Like Receptor 7/9 Activation.

J. Ruben,1 G. Garcia-Romo,1 E. Breman,1 S. van der Kooij,1 A. Redeker,2 R. Arens,2 C. van Kooten.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
TNT009 and Its Parental Mouse Monoclonal Antibody TNT003 Target Complement Component C1s and Effectively Block Alloantibody-Induced Classical Complement Pathway Activation – The Preclinical Experience.

M. Wahrmann,1 J. Mühlbacher,1 H. Regele,1 F. Eskandary,1 J. Gilbert,2 S. Panicker,2 G. Böhmig.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Tofacitinib Delivered by Solid Lipid Nanoparticles Inhibits Dendritic Cell Maturation and Their Allostimulatory Capacity.

J. Budihardjo,1 M. Iglesias,1 J. Walch,1 X. Calderon-Colon,2 W. Lee,1 G. Brandacher,1 J. Patrone,2 G. Raimondi.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Tool to Assess Risk of Non-Adherence in Renal Transplant Candidates.

T. Kaiser,1 K. Daley,2 L. Dick,2 L. Deye,2 N. Parrish,2 J. Huff,2 A. Govil,1 B. Abu Jawdeh,1 G. Mogilishetty,1 R. Alloway,1 E. Woodle.1

Poster Session D: Psychosocial and Treatment Adherence  •  Halls C&D
  • «Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • Next Page»

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences